The Columbia COVID-19 Biobank has been up and running for just three weeks. The idea is to lend immediate support and invaluable resources to investigators working toward a cure for COVID-19.
The Flow Cytometry Shared Resource at the HICCC supports a wide variety of studies related to cancer biology, functional genomics and tumor immunology using the newest techniques.
The High Throughput Screening shared resource is equipped with state-of-the-art instrumentation, robotic automation, and software for running high-throughput screens using assay technologies.
The Molecular Pathology Shared Resource (MPSR) is a comprehensive service for researchers and scientists conducting cutting-edge experimental, basic science, and translational research at the HICCC.
In a span of just a few weeks, Kenneth Olive, PhD, has galvanized a team of volunteers—primarily students, postdocs, and staff scientists—to assist with the surging COVID-19 response across CUIMC.
CovidWatcher works as a crowd-sourcing research platform that surveys users—both healthy and potentially exposed to COVID-19—about their exposure to the virus, symptoms, and access to medical care.
Researchers from the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia are swiftly transforming their discoveries and innovation in cancer to address COVID-19.